Concurrent Investment Advisors’s Ingevity NGVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$828K Sell
11,093
-2
-0% -$144 0.01% 1116
2026
Q1
$790K Buy
11,095
+260
+2% +$17.8K 0.01% 981
2025
Q4
$641K Buy
10,835
+40
+0.4% +$2.17K 0.01% 1038
2025
Q3
$596K Sell
10,795
-10,684
-50% -$556K 0.01% 843
2025
Q2
$926K Sell
21,479
-98
-0.5% -$3.78K 0.02% 616
2025
Q1
$854K Buy
+21,577
New +$955K 0.02% 591

Other funds holding NGVT

Concurrent Investment Advisors's NGVT Position: Q2 2026 in Review

Concurrent Investment Advisors reduced its Ingevity (NGVT) stake by 0.02% in Q2 2026, selling an estimated $144 and leaving 11,093 shares worth $828K. The position accounts for 0.01% of the portfolio, ranked #1116.

Concurrent Investment Advisors first reported a position in NGVT in Q1 2025 and has held it in 6 quarters since. The position peaked at $926K in Q2 2025. 316 funds tracked by Wall St. Rank hold NGVT as of Q2 2026.

  • Concurrent Investment Advisors held 11,093 shares of Ingevity worth $828K as of Q2 2026.
  • Concurrent Investment Advisors sold 2 Ingevity shares in Q2 2026, an estimated $144.
  • Ingevity made up 0.01% of Concurrent Investment Advisors's portfolio in Q2 2026, its #1116 holding.
  • Concurrent Investment Advisors first reported a position in Ingevity in Q1 2025 and has held it in 6 quarters since.
  • Concurrent Investment Advisors's Ingevity position peaked at $926K in Q2 2025.
  • 316 funds tracked by Wall St. Rank held Ingevity as of Q2 2026.

Based on Concurrent Investment Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.